European Parliament Event on Direct Patient Reporting
On 15 September the European Patients’ Forum (EPF), together with the Pharmaceutical Group of the European Union (PGEU), organised a lunch seminar entitled “Adverse Drug Reactions: Moving Forward Together on Patient Safety” that took a critical look at the Direct Patient Reporting, part of the Pharmacovigilance legislation. The seminar was hosted by Linda McAvan, Member of the European Parliament and Rapporteur on the draft directive on Pharmacovigilance within the European Parliament.
A wide range of stakeholders were invited to hear the views of pharmacists’ and patients’ representatives, regulators (including the European Medicines Agency and the MHRA1), academics (the Netherlands Pharmacovigilance Centre Lareb), the European Commission and the pharmaceutical industry. They discussed the new directive, which emphasizes a stronger reporting framework for pharmacists and health professionals, and a direct reporting by patients. The data gathered from such reports will be used to monitor risks posed by medicines once they have been approved and become available to patients.
A full report of the seminar is available here.